HCA Healthcare (HCA) Stock Price

HCA Healthcare Price

NYSE·CLOSED
404.68USD+0.0000 (+0.00 %)
Market closed

Revenue has compounded at 5.9% per year over the past 19 years to 75.60 B USD. Earnings per share have grown at 14.0% per year over the last 19 years. HCA Healthcare's net margin stands at 9.0%, down from 11.8% several years earlier. HCA Healthcare currently offers a dividend yield of about 0.71%. The payout ratio is around 10% of earnings. Analysts set a median price target of 558.96 USD, implying 38.1% above the current price. Of 31 analysts, 18 rate the stock a buy — an overall Buy consensus. The stock trades about 12% above its 52-week low.

HCA Healthcare stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of HCA Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how HCA Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing HCA Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

HCA Healthcare Stock Price History
DateHCA Healthcare Price
8/14/2026404.68 USD
8/13/2026411.74 USD
8/12/2026414.59 USD
8/11/2026411.44 USD
8/10/2026412.67 USD
8/7/2026413.36 USD
8/6/2026408.89 USD
8/5/2026409.93 USD
8/4/2026397.27 USD
8/3/2026406.61 USD
7/31/2026402.59 USD
7/30/2026395.79 USD
7/29/2026408.84 USD
7/27/2026389.96 USD
7/23/2026376.50 USD
7/22/2026371.87 USD
7/21/2026373.09 USD
7/20/2026370.42 USD
7/17/2026371.18 USD
7/16/2026385.74 USD
7/15/2026378.85 USD
7/14/2026363.60 USD
7/13/2026401.10 USD
7/10/2026406.59 USD
7/9/2026409.01 USD
7/8/2026410.64 USD
7/7/2026423.11 USD
7/6/2026411.93 USD
7/2/2026410.50 USD
7/1/2026393.24 USD
6/30/2026389.89 USD
6/29/2026390.53 USD
6/26/2026391.68 USD
6/25/2026386.94 USD
6/24/2026387.76 USD
6/23/2026386.92 USD
6/22/2026375.80 USD
6/18/2026378.26 USD
6/17/2026393.90 USD
6/16/2026398.00 USD
6/15/2026390.62 USD
6/12/2026385.63 USD
6/11/2026375.41 USD
6/10/2026375.79 USD
6/9/2026374.90 USD
6/8/2026361.32 USD
6/5/2026369.04 USD
6/4/2026363.74 USD
6/3/2026362.57 USD
6/2/2026368.95 USD
6/1/2026369.45 USD
5/29/2026383.36 USD
5/28/2026388.16 USD
5/27/2026395.33 USD
5/26/2026390.70 USD
5/22/2026390.11 USD
5/21/2026394.84 USD
5/20/2026402.48 USD
5/19/2026404.69 USD
5/18/2026422.79 USD
5/15/2026423.00 USD
5/14/2026432.70 USD
5/13/2026427.54 USD
5/12/2026429.69 USD
5/11/2026426.37 USD
5/8/2026435.19 USD
5/7/2026429.02 USD
5/6/2026429.45 USD
5/5/2026428.79 USD
5/4/2026427.18 USD
5/1/2026433.09 USD
4/30/2026434.45 USD
4/29/2026434.78 USD
4/28/2026431.92 USD
4/27/2026445.77 USD
4/24/2026432.46 USD
4/23/2026474.03 USD
4/22/2026471.34 USD
4/21/2026471.18 USD
4/20/2026478.13 USD
4/17/2026488.00 USD
4/16/2026482.97 USD
4/15/2026488.58 USD
4/14/2026498.66 USD
4/13/2026497.42 USD
4/10/2026495.47 USD
4/9/2026507.19 USD
4/8/2026505.12 USD
4/7/2026489.58 USD
4/6/2026483.92 USD
4/2/2026469.15 USD
4/1/2026474.75 USD
3/31/2026473.24 USD
3/30/2026467.83 USD
3/27/2026471.85 USD
3/26/2026480.32 USD
3/25/2026484.02 USD
3/24/2026485.72 USD
3/23/2026494.58 USD
3/20/2026493.88 USD
3/19/2026499.65 USD
3/18/2026499.65 USD
3/17/2026509.87 USD
3/16/2026525.19 USD
3/13/2026536.37 USD
3/12/2026532.58 USD
3/11/2026537.28 USD
3/10/2026537.64 USD
3/9/2026545.13 USD
3/6/2026532.81 USD
3/5/2026534.47 USD
3/4/2026544.41 USD
3/3/2026541.80 USD
3/2/2026532.92 USD
2/27/2026529.70 USD
2/26/2026525.90 USD
2/25/2026540.57 USD
2/24/2026533.99 USD
2/23/2026535.97 USD
2/20/2026532.30 USD
2/19/2026528.66 USD
2/18/2026535.02 USD
2/17/2026534.78 USD
2/16/2026534.78 USD
2/13/2026540.29 USD
2/12/2026540.29 USD
2/11/2026535.22 USD
2/10/2026531.47 USD
2/9/2026502.05 USD
2/8/2026497.54 USD
2/6/2026501.69 USD
2/5/2026501.69 USD
2/4/2026513.76 USD
2/3/2026493.64 USD
2/2/2026499.21 USD
2/1/2026496.85 USD
1/30/2026488.27 USD
1/29/2026488.27 USD
1/28/2026482.53 USD
1/27/2026491.23 USD
1/26/2026505.84 USD
1/25/2026472.38 USD
1/23/2026470.88 USD
1/22/2026470.88 USD
1/21/2026466.34 USD
1/20/2026465.44 USD
1/19/2026464.38 USD
1/16/2026469.29 USD
1/15/2026469.29 USD
1/14/2026483.80 USD
1/13/2026478.84 USD
1/12/2026479.32 USD
1/11/2026474.32 USD
1/9/2026472.07 USD
1/8/2026472.07 USD
1/7/2026479.02 USD
1/6/2026470.65 USD
1/5/2026483.60 USD
1/4/2026477.83 USD
1/2/2026470.39 USD
1/1/2026470.39 USD
12/31/2025466.86 USD
12/30/2025466.86 USD
12/29/2025473.26 USD
12/28/2025474.02 USD
12/26/2025477.13 USD
12/25/2025477.13 USD
12/24/2025474.06 USD
12/23/2025474.06 USD
12/22/2025474.04 USD
12/21/2025472.03 USD
12/19/2025472.98 USD
12/18/2025472.98 USD
12/17/2025466.56 USD
12/16/2025471.85 USD
12/15/2025469.79 USD
12/14/2025476.98 USD
12/12/2025484.77 USD
12/11/2025484.77 USD
12/10/2025482.35 USD
12/9/2025468.73 USD
12/8/2025488.50 USD
12/7/2025485.15 USD
12/5/2025486.70 USD
12/4/2025486.70 USD
12/3/2025487.66 USD
12/2/2025486.77 USD
12/1/2025500.31 USD
11/30/2025503.00 USD
11/28/2025508.29 USD
11/27/2025508.29 USD
11/26/2025514.76 USD
11/25/2025514.76 USD
11/24/2025515.85 USD
11/23/2025501.04 USD
11/21/2025491.00 USD
11/20/2025491.00 USD
11/19/2025476.28 USD
11/18/2025481.06 USD
11/17/2025478.14 USD
11/16/2025477.10 USD
11/14/2025472.65 USD
11/13/2025472.65 USD
11/12/2025473.28 USD
11/11/2025473.61 USD
11/10/2025462.31 USD
11/9/2025459.30 USD
11/7/2025476.61 USD
11/6/2025476.61 USD
11/5/2025471.36 USD
11/4/2025473.20 USD
11/3/2025471.68 USD
11/2/2025461.56 USD
10/31/2025459.68 USD
10/30/2025459.68 USD
10/29/2025466.80 USD
10/28/2025468.40 USD
10/27/2025466.46 USD
10/26/2025467.86 USD
10/23/2025447.04 USD
10/22/2025440.16 USD
10/21/2025441.19 USD
10/20/2025432.01 USD
10/19/2025433.15 USD
10/16/2025426.16 USD
10/15/2025419.60 USD
10/14/2025420.25 USD
10/13/2025418.40 USD
10/12/2025410.68 USD
10/9/2025415.14 USD
10/8/2025418.87 USD
10/7/2025426.27 USD
10/6/2025437.57 USD
10/5/2025433.55 USD
10/2/2025429.54 USD
10/1/2025426.69 USD
9/30/2025426.07 USD
9/29/2025426.20 USD
9/28/2025420.92 USD
9/25/2025419.08 USD
9/24/2025414.89 USD
9/23/2025416.62 USD
9/22/2025409.45 USD
9/21/2025407.24 USD
9/18/2025402.30 USD
9/17/2025401.06 USD
9/16/2025399.39 USD
9/15/2025399.75 USD
9/14/2025403.17 USD
9/11/2025405.13 USD
9/10/2025402.85 USD
9/9/2025394.36 USD
9/8/2025413.40 USD
9/7/2025418.10 USD
9/4/2025420.77 USD
9/3/2025411.59 USD
9/2/2025407.61 USD
9/1/2025406.14 USD
8/28/2025403.96 USD
8/27/2025407.28 USD
8/26/2025405.05 USD
8/25/2025401.96 USD
8/24/2025402.77 USD
8/21/2025404.97 USD
8/20/2025404.26 USD
8/19/2025410.18 USD
8/18/2025402.69 USD
8/17/2025393.62 USD
Access this data via the Eulerpool API
Get Free API Key

HCA Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
64.97 B USD
9.63 B USD
5.24 B USD
Jan 1, 2024
70.60 B USD
10.58 B USD
5.76 B USD
Jan 1, 2025
75.60 B USD
14.21 B USD
6.78 B USD
Jan 1, 2026 (e)
78.52 B USD
12.93 B USD
7.07 B USD
Jan 1, 2027 (e)
81.63 B USD
13.48 B USD
7.69 B USD
Jan 1, 2028 (e)
85.95 B USD
14.16 B USD
8.77 B USD
Jan 1, 2029 (e)
91.73 B USD
15.11 B USD
10.12 B USD
Jan 1, 2030 (e)
97.96 B USD
16.13 B USD
11.67 B USD

HCA Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 17, 2026, 4:30 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
39.6841.4943.6146.6851.3451.5358.7560.2364.9770.6075.6078.5281.6385.9591.7397.96
7.484.575.127.029.980.3814.012.527.868.677.083.863.975.296.736.79
83.2783.2983.2383.4583.4883.7638.2838.4839.3740.6241.5041.5041.5041.5041.5041.50
33.0434.5636.3038.9542.8643.1622.4923.1825.5828.6831.3732.5833.8835.6738.0740.65
5.976.206.066.647.227.2611.249.059.6310.5814.2112.9313.4814.1615.1116.13
15.0314.9413.8914.2314.0614.0919.1415.0314.8214.9918.8016.4716.5116.4716.4716.47
2.132.892.223.793.513.756.965.645.245.766.787.077.698.7710.1211.67
13.5535.74-23.3270.89-7.457.1085.30-18.88-7.119.8817.784.228.8113.9315.4415.34
–––1.401.601.401.922.242.402.642.883.123.513.95––
––––14.29-12.5037.1416.677.1410.009.098.3312.5012.54––
415.92384.75363.94352.88346.79345.37315.42285.66271.19255.31230.71230.71230.71230.71230.71230.71
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales HCA Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue HCA Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare HCA Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares HCA Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against HCA Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

HCA Healthcare stock margins

The HCA Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of HCA Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for HCA Healthcare.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
38.28 %
19.14 %
11.84 %
Jan 1, 2022
38.48 %
15.03 %
9.37 %
Jan 1, 2023
39.37 %
14.82 %
8.07 %
Jan 1, 2024
40.62 %
14.99 %
8.16 %
Jan 1, 2025
41.50 %
18.80 %
8.97 %
Jan 1, 2026 (e)
41.50 %
16.47 %
9.01 %
Jan 1, 2027 (e)
41.50 %
16.51 %
9.42 %
Jan 1, 2028 (e)
41.50 %
16.47 %
10.20 %

HCA Healthcare Stock Revenue, EBIT, Earnings per Share

The HCA Healthcare earnings per share therefore indicates how much revenue HCA Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
186.27 USD
35.65 USD
22.05 USD
Jan 1, 2022
210.85 USD
31.69 USD
19.75 USD
Jan 1, 2023
239.57 USD
35.50 USD
19.33 USD
Jan 1, 2024
276.54 USD
41.46 USD
22.56 USD
Jan 1, 2025
327.68 USD
61.61 USD
29.40 USD
Jan 1, 2026 (e)
327.84 USD
56.06 USD
29.52 USD
Jan 1, 2027 (e)
340.86 USD
58.43 USD
32.12 USD
Jan 1, 2028 (e)
358.88 USD
61.36 USD
36.60 USD

HCA Healthcare business model & stock analysis

HCA Healthcare Inc is one of the largest healthcare service companies in the world. It was founded in 1968 and is headquartered in Nashville, Tennessee. HCA Healthcare is known for its hospital chain and currently operates over 2,000 hospitals, outpatient facilities, surgery centers, rehabilitation centers, and nursing homes in 21 states in the US, as well as in the UK. The company employs over 280,000 employees. HCA Healthcare's business model is based on providing high-quality healthcare services. The company is committed to its patients and offers a wide range of services, ranging from medical care to rehabilitation. HCA Healthcare relies on advanced technology to ensure the best possible medical care for its patients. One of HCA Healthcare's divisions is the Acute Care Division, which focuses on acute patient care. This includes hospitals, operating rooms, and intensive care units where both emergency and routine procedures are performed. Another business area is the Physician Services Division, which offers specialized medical and health services such as dentistry or ophthalmology. The company also provides specialized services for cancer patients. The Sarah Cannon Cancer Institute is a leading provider of cancer treatments and clinical trials in the US and the UK. Patients are treated by experts specifically trained in cancer treatment. In addition to these services, HCA Healthcare also offers specialized programs for mental health. One of the most well-known facilities is Belmont Behavioral Health, which specializes in the treatment of mental illnesses such as addiction and depression. Another important area of ​​HCA Healthcare is the IT segment. The company invests in digital technologies to collect and manage patient data more intelligently in order to achieve better outcomes for its patients. It is not only about better data management but also about integrating science, technology, and medicine in the healthcare supply chain. In the past, the company has also made negative headlines. It was fined $1.7 billion for allegedly billing for unauthorized medical services. However, HCA Healthcare has worked hard to restore its image and is committed to improving the quality of healthcare services. In summary, HCA Healthcare Inc is a leading company in the healthcare industry that focuses on providing high-quality services for its patients. The focus is primarily on acute patient care and rehabilitation, as well as specialized services for cancer and mental health. The company relies on advanced technology and integrates science, medicine, and technology to ensure the best possible care for its patients.

HCA Healthcare SWOT Analysis

Strengths

HCA Healthcare Inc (HCA) is one of the largest hospital operators in the United States, with a vast network of facilities and healthcare providers. This expansive infrastructure provides the company with a strong competitive advantage.

HCA has established a reputation for delivering high-quality healthcare services, leading to patient satisfaction and positive word-of-mouth referrals. This brand value contributes to the company's overall strength in the market.

The company's efficient cost management practices and economies of scale allow HCA to deliver healthcare services at competitive prices while maintaining profitability. This financial stability is a significant strength for HCA.

Weaknesses

HCA operates in a highly regulated industry, which subjects the company to various compliance requirements and potential legal risks. These challenges can impact HCA's operations and financial performance.

The company's heavy reliance on third-party payers, such as insurance companies and government reimbursement programs, exposes HCA to potential changes in reimbursement rates and policies. This vulnerability poses a weakness for the company.

HCA's large size and complex organizational structure can sometimes lead to bureaucracy, slowing decision-making processes and hindering agility. This weakness may impact the company's ability to adapt quickly to market changes.

Opportunities

The growing aging population and increasing healthcare needs present significant opportunities for HCA. This demographic trend will likely result in higher demand for healthcare services, allowing HCA to expand its patient base.

Advancements in technology, such as telemedicine and data analytics, offer opportunities for HCA to improve operational efficiency and enhance patient care. By embracing these innovations, HCA can stay ahead of competitors and attract tech-savvy consumers.

HCA's extensive network of hospitals and healthcare facilities positions the company to pursue strategic partnerships and acquisitions. Collaborations with other industry players can lead to synergies, expanded services, and geographical market expansion.

Threats

The ongoing healthcare reform landscape and potential changes in government policies pose threats to HCA's business. Alterations in reimbursement rates, regulations, and coverage could impact the company's revenue streams and profitability.

Intense competition within the healthcare industry presents a threat to HCA. Competitors offering similar services may attract potential patients away from HCA's facilities, putting pressure on the company's market share.

Healthcare industry trends, such as the shift toward outpatient services and the rise of alternative healthcare providers, may disrupt HCA's traditional business model. To mitigate this threat, HCA needs to continuously adapt and diversify its service offerings.

HCA Healthcare Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

HCA Healthcare Employees
Details
Date
HCA Healthcare Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

HCA Healthcare Segments

HCA Healthcare Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Product and Service, Other
Details
Date
Product and Service, Other
Jan 1, 2018
1.97 B USD
Jan 1, 2019
2.36 B USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD

HCA Healthcare Revenue by Segment (2/3)

  • 3 Years

  • Max

Other
Product and Service, Other
Details
Date
Other
Product and Service, Other
Jan 1, 2018
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
2.84 B USD
Jan 1, 2022
3.51 B USD
0.00 USD
Jan 1, 2024
0.00 USD
2.54 B USD
Jan 1, 2025
0.00 USD
2.46 B USD

HCA Healthcare Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • Max

National Group
American Group
Corporate and Other
Details
Date
National Group
American Group
Corporate and Other
Jan 1, 2018
22.58 B USD
21.96 B USD
2.14 B USD
Jan 1, 2019
25.91 B USD
23.17 B USD
2.25 B USD
Jan 1, 2021
29.83 B USD
26.15 B USD
2.77 B USD
Jan 1, 2022
30.35 B USD
26.87 B USD
3.02 B USD
Jan 1, 2024
0.00 USD
0.00 USD
3.22 B USD
Jan 1, 2025
0.00 USD
0.00 USD
3.17 B USD

HCA Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

HCA Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

HCA Healthcare annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

HCA Healthcare shares outstanding

The number of shares of HCA Healthcare was 230.71 M in 2025. This indicates how many shares HCA Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
315.42 M Stocks
Jan 1, 2022
285.66 M Stocks
Jan 1, 2023
271.19 M Stocks
Jan 1, 2024
255.31 M Stocks
Jan 1, 2025
230.71 M Stocks
Jan 1, 2026 (e)
230.71 M Stocks
Jan 1, 2027 (e)
230.71 M Stocks
Jan 1, 2028 (e)
230.71 M Stocks

HCA Healthcare Dividend History

10 years of dividend payments · 5 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.78USDYTD—1×
Mar 17, 20260.78USD↑ 8.3%1/1
20252.88USD↑ 9.1%4×
Mar 17, 20250.72USD↑ 9.1%1/4
Jun 16, 20250.72USD 0.0%2/4
Sep 16, 20250.72USD 0.0%3/4
Dec 15, 20250.72USD 0.0%4/4
20242.64USD↑ 10.0%4×
20232.40USD↑ 7.1%4×
20222.24USD↑ 16.7%4×
20211.92USD↑ 175.1%4×
20200.70USD↓ 56.4%2×
20191.60USD↑ 14.3%4×
20181.40USD↓ 78.5%4×
20126.50USD—3×

HCA Healthcare dividend history and estimates

In 2025, HCA Healthcare paid a dividend amounting to 2.88 USD. Dividend means that HCA Healthcare distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
1.92 USD
0.00 USD
0.00 USD
Jan 1, 2022
2.24 USD
0.00 USD
0.00 USD
Jan 1, 2023
2.40 USD
0.00 USD
6.50 USD
Jan 1, 2024
2.64 USD
0.00 USD
0.00 USD
Jan 1, 2025
2.88 USD
0.00 USD
0.00 USD
Jan 1, 2026 (e)
0.78 USD
2.34 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
3.51 USD
0.00 USD
Jan 1, 2028 (e)
0.00 USD
3.95 USD
0.00 USD

HCA Healthcare dividend payout ratio

In 2025, HCA Healthcare had a payout ratio of 9.79%. The payout ratio indicates the percentage of the company's profits that HCA Healthcare distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
8.71 %
Jan 1, 2022
11.34 %
Jan 1, 2023
12.42 %
Jan 1, 2024
11.70 %
Jan 1, 2025
9.79 %
Jan 1, 2026 (e)
10.57 %
Jan 1, 2027 (e)
10.92 %
Jan 1, 2028 (e)
10.78 %

Current HCA Healthcare forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
11.38 %
Buy
58.06 % (18)
Hold
38.71 % (12)
Sell
3.23 % (1)
12M Price Target
558.96
Last Price
404.68
Currency
USD
12M Return Potential
38.12 %
LTM Return
0 %

HCA Healthcare Analyst Rating Actions

DateFirmActionRatingReliability
7/28/2026
Mizuho
Mizuho
MaintainedOutperform31
7/28/2026
Goldman Sachs
Goldman Sachs
MaintainedBuy–
7/27/2026
UBS
UBS
MaintainedBuy51
7/27/2026
Truist Securities
Truist Securities
MaintainedBuy–
7/27/2026
RBC Capital
RBC Capital
MaintainedOutperform52
7/27/2026
Oppenheimer
Oppenheimer
MaintainedOutperform65
7/27/2026
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
7/27/2026
Keybanc
Keybanc
MaintainedOverweight49
7/27/2026
Barclays
Barclays
MaintainedEqual Weight33
7/27/2026
Baird
Baird
MaintainedNeutral–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

HCA Healthcare Earnings Calls

2025
2024

HCA Healthcare Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/23/20267.49USD-19.58 BUSD-2026 Q2
4/24/20267.24USD-19.28 BUSD-2026 Q1
1/27/20267.53USD-19.86 BUSD-2025 Q4
4/19/20244.80USD-16.69 BUSD-2024 Q1
1/25/20245.10USD-16.63 BUSD-2023 Q4
7/20/20234.52USD-15.72 BUSD-2023 Q2
4/20/20234.40USD-15.64 BUSD-2023 Q1
1/25/20234.82USD-15.80 BUSD-2022 Q4
10/21/20223.92USD-15.23 BUSD-2022 Q3
7/22/20223.74USD-14.95 BUSD-2022 Q2

EESG©

Eulerpool ESG Scorecard© for the HCA Healthcare stock

65/100
63
Environment
70
Social
61
Governance
E

Environment

20
Scope 1 - Direct Emissions754,671
Scope 2 - Indirect emissions from purchased energy1,298,810
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions2,053,480
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees78
Percentage of women in management—
Percentage of Asian employees8
Share of Asian management—
Percentage of Hispanic/Latino employees18
Hispano/Latino Management share—
Percentage of Black employees17
Black Management Share—
Percentage of white employees55
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

HCA Healthcare shareholder structure

% Name
5.57977%
BLACKROCK, INC.
BLACKROCK, INC.
4.24993%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
3.74001%
SANDERS CAPITAL, LLC
SANDERS CAPITAL, LLC
3.14810%
STATE STREET CORP
STATE STREET CORP
1.83763%
FMR LLC
FMR LLC
1.63165%
WELLINGTON MANAGEMENT GROUP LLP
WELLINGTON MANAGEMENT GROUP LLP
...

HCA Healthcare Beneficial Ownership Filings (SEC 13D/G)

Free Float
67.6%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
31.60%
Thomas F. Frist, Jr.
Thomas F. Frist, Jr.
SEC ↗
31.50%
William R. Frist
William R. Frist
SEC ↗
31.40%
Patricia F. Elcan
Patricia F. Elcan
SEC ↗
31.30%
Thomas F. Frist III
Thomas F. Frist III
SEC ↗
20.50%
Patricia C. Frist
Patricia C. Frist
SEC ↗
20.40%
in Row (9)
in Row (9)
SEC ↗
20.30%
20.3%*
20.3%*
SEC ↗
20.00%
20.0%*
20.0%*
SEC ↗
19.50%
10.
10.
SEC ↗
17.40%
Frisco Holding II
Frisco Holding II
SEC ↗

HCA Healthcare Executives and Management Board

18 members · avg. age 61 · 28 % women

SH

Mr. Samuel Hazen (64)

Chief Executive Officer, Director · since 2010

23.80 M USD

Management

JF

Mr. Jon Foster (63)

Chief Operating Officer, Executive Vice President

9.17 M USD
MM

Mr. Michael Mcalevey (61)

Executive Vice President, Chief Legal and Administrative Officer

5.74 M USD
MC

Dr. Michael Cuffe (59)

Executive Vice President, Chief Clinical Officer

5.54 M USD
MM

Mr. Michael Marks (55)

Chief Financial Officer, Executive Vice President

5.51 M USD
JB

Ms. Jennifer Berres (54)

Senior Vice President, Chief Human Resources Officer

–
MC

Ms. Monica Cintado

Senior Vice President of development

–

Board of Directors

TF

Mr. Thomas Frist (57)

Chairman of the Board · since 2006

399,863.00 USD
MM

Mr. Michael Michelson (73)

Independent Director

389,759.00 USD
WR

Dr. Wayne Riley (65)

Independent Director

349,966.00 USD
RD

Mr. Robert Dennis (71)

Independent Director

344,897.00 USD
HJ

Mr. Hugh Johnston (63)

Independent Director

339,966.00 USD
ND

Ms. Nancy-Ann DeParle

Independent Director

334,966.00 USD

HCA Healthcare Supply Chain

HCA Healthcare Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
25 companies
#Nameβ 1YTrend
1
Cross Country Healthcare, Inc.
Supplier·Health Care Providers & Services·US
-0.11
0.72
0.58
0.14
0.44
0.93
—
2
Healthpeak Properties, Inc.
Supplier·Equity Real Estate Investment Trusts (REITs)·US
-0.63
0.62
0.17
0.19
0.21
0.92
—
3
Omnicell, Inc.
Customer·Health Care Equipment & Supplies·US
0.63
0.72
0.47
0.02
0.14
0.88
0.25
4
ePlus inc.
Customer·Electronic Equipment, Instruments & Components·US
-0.49
-0.75
-0.24
-0.09
0.39
0.85
0.54
5
Brookdale Senior Living
Supplier·Customer·Health Care Providers & Services·US
-0.33
0.84
0.64
0.26
-0.35
0.82
—
#Nameβ 1YTrend
1
Pluralsight, Inc.
Supplier·US
0.73
-0.47
-0.47
-0.06
—
—
—
2
Oscar Health A
Supplier·Insurance·US
-0.26
0.79
0.34
0.14
-0.50
—
-1.41
3
DocGo
Supplier·Health Care Providers & Services·US
-0.74
0.81
0.33
0.29
-0.12
—
—
4
BioSig Technologies
Supplier·Health Care Equipment & Supplies·US
0.42
0.84
0.42
-0.06
-0.42
-0.84
—
5
MedAvail Holdings, Inc
Customer·Food & Staples Retailing·US
-0.41
0.37
-0.35
-0.36
-0.68
-0.84
—

Frequently asked questions about HCA Healthcare

The business model of HCA Healthcare Inc revolves around providing high-quality healthcare services across the United States. As one of the leading providers of healthcare services, HCA operates a diverse network of hospitals, freestanding surgery centers, and physician practices. The company focuses on delivering exceptional patient care, utilizing advanced medical technologies, and fostering strong partnerships with physicians and healthcare providers. With a commitment to continuous improvement and innovation, HCA strives to enhance patient outcomes and deliver value-based healthcare. Through its extensive presence in various communities, HCA Healthcare Inc aims to meet the evolving healthcare needs of patients and promote overall well-being.

HCA Healthcare Inc is primarily active in the healthcare industry.

The main competitors of HCA Healthcare Inc in the market are Tenet Healthcare Corporation, Community Health Systems Inc, and Universal Health Services Inc.

HCA Healthcare Inc. is a renowned healthcare services provider based in the United States. Founded in 1968, the company has a rich history and extensive background in delivering exceptional patient care. HCA Healthcare has grown to become one of the largest hospital operators in the country, operating numerous hospitals, surgical centers, and other healthcare facilities. With a strong focus on quality, innovation, and compassion, HCA Healthcare continues to strive for excellence in delivering healthcare services. The company is committed to utilizing advanced technologies and industry-leading practices to ensure patients receive the best possible care. HCA Healthcare Inc. has firmly established itself as a trusted leader in the healthcare industry.

HCA Healthcare Inc has achieved several significant milestones throughout its history. The company's commitment to providing high-quality healthcare services has enabled it to become one of the leading healthcare providers in the United States. Notable achievements include being recognized as a Fortune 500 company, expanding its footprint to over 180 hospitals and approximately 2,000 healthcare sites of service, and consistently delivering outstanding patient outcomes. Additionally, HCA Healthcare Inc has received numerous accolades for its clinical excellence, innovative technologies, and commitment to patient care. These milestones highlight the company's dedication to delivering exceptional healthcare services and solidify its position as a trusted and reliable healthcare provider.

HCA Healthcare Inc is primarily present in the United States. With its headquarters in Nashville, Tennessee, HCA Healthcare operates a vast network of hospitals, outpatient centers, and clinics across various states. Serving millions of patients each year, HCA Healthcare is one of the largest healthcare providers in the country. The company's presence spans over 20 states, including major cities such as Houston, Dallas, and Las Vegas. Additionally, HCA Healthcare Inc has partnerships with international hospitals and facilities in the United Kingdom and Switzerland, further extending its global reach.

HCA Healthcare Inc represents a set of values and corporate philosophy that prioritize exceptional patient care, integrity, and continuous improvement. With a commitment to putting patients first, HCA Healthcare Inc strives to deliver high-quality healthcare services driven by innovation, compassion, and accountability. The company's philosophy revolves around maintaining a patient-centric approach, ensuring access to advanced medical technologies, promoting personal and professional growth of their workforce, and fostering a culture of collaboration and transparency. By adhering to these values, HCA Healthcare Inc has established itself as a leading provider of comprehensive healthcare services, dedicated to positively impacting patients' lives.

Analysts currently set an average price target of 537.27 USD for the HCA Healthcare stock (median: 558.96 USD), implying +32.8 % versus the latest price. The consensus is based on 31 analyst ratings.

HCA Healthcare Analyst Price Targets 2026

31 analysts currently rate the HCA Healthcare stock: 18 recommend buying, 12 holding and 1 selling. For 2026, analysts expect HCA Healthcare to generate revenue of 78.52 B USD and earnings per share of 30.65 USD.

HCA Healthcare Analyst Price Targets 2026

Converted at the current exchange rate, the HCA Healthcare share trades at 349.71 EUR (404.68 USD).

The HCA Healthcare share (HCA) is listed on 8 stock exchanges, including: NYSE (HCA), Frankfurt (2BH.F), München (2BH.MU), Düsseldorf (2BH.DU), London (0J1R.L), London (0J1R.L), SIX (Zürich) (2BH.SW).

HCA Healthcare Inc. is one of the largest healthcare companies in the USA, offering a wide range of medical services. The company's business model is based on operating hospitals, medical centers, and clinics. HCA Healthcare currently operates over 185 hospitals and 120 outpatient surgical centers in 20 US states and in the UK. HCA Healthcare's hospitals and medical centers offer a variety of services, including emergency medicine, oncology, cardiology, neurology, orthopedics, internal medicine, and many others. An important part of HCA Healthcare's business model is to provide high-quality medical services tailored to the needs of patients. The company relies on advanced technologies and innovative approaches to improve treatment outcomes for patients. HCA Healthcare also offers a comprehensive health plan that covers patients' needs from birth to end of life. This plan includes insurance benefits, preventive screenings, and a range of health programs to support patients in improving and maintaining their health. Another important branch of HCA Healthcare's business is the management of hospitals and medical centers for third parties. The company offers a comprehensive package of management services for hospitals and health systems, including operational support, staff management, and compliance management. In addition to these offerings, HCA Healthcare continues to expand its portfolio of medical services. For example, the company has partnered with the Mayo Clinic to provide its patients with access to the Mayo Clinic's innovative diagnostic and therapeutic technologies. HCA Healthcare also offers a range of education and research opportunities. The company operates its own research institute and collaborates with a variety of academic institutions to advance medical advancements. In summary, HCA Healthcare's business model is focused on providing the best medical services to its patients in the USA and the UK. The company relies on innovative approaches and advanced technologies to improve both medical treatment outcomes and the patient experience. The wide portfolio of medical services, partnerships with other healthcare actors, and the offering of management services make HCA Healthcare an important player in the healthcare industry.

The expected revenue of HCA Healthcare is 78.52 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of HCA Healthcare is 7.07 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of HCA Healthcare is currently 13.20. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the HCA Healthcare stock.

The price-to-sales ratio (P/S) of HCA Healthcare is currently 1.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the HCA Healthcare stock.

The Eulerpool Quality Score for HCA Healthcare is 8/10.

The ISIN of HCA Healthcare is US40412C1018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of HCA Healthcare is A1JFMW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of HCA Healthcare is HCA. The ticker symbol is used to trade HCA Healthcare shares on the stock exchange.

Over the past 12 months, HCA Healthcare paid a dividend of 2.88 USD . This corresponds to a dividend yield of about 0.71 %. For the coming 12 months, HCA Healthcare is expected to pay a dividend of 3.51 USD.

The current dividend yield of HCA Healthcare is 0.71 %.

HCA Healthcare pays a dividend, distributed in the months of , , , .

HCA Healthcare paid dividends every year for the past 8 years.

For the upcoming 12 months, dividends amounting to 3.51 USD are expected. This corresponds to a dividend yield of 0.87 %.

HCA Healthcare is assigned to the 'Health' sector.

To receive the latest dividend of HCA Healthcare from amounting to 0.78 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, HCA Healthcare distributed 2.64 USD as dividends.

The dividends of HCA Healthcare are distributed in USD.

All fundamentals and in-depth analysis of HCA Healthcare

Our stock analysis for HCA Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HCA Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

HCA Healthcare Stock
HCA Healthcare Revenue→
HCA Healthcare Stock
HCA Healthcare Net Income→
HCA Healthcare Stock
HCA Healthcare P/E→
HCA Healthcare Stock
HCA Healthcare P/S→
HCA Healthcare Stock
HCA Healthcare EBIT→
HCA Healthcare Stock
HCA Healthcare Dividend→
HCA Healthcare Stock
HCA Healthcare Directors Dealings→
HCA Healthcare Stock
HCA Healthcare Stocks→
HCA Healthcare Stock
HCA Healthcare Market capitalization→
HCA Healthcare Stock
HCA Healthcare Debt→
HCA Healthcare Stock
HCA Healthcare Liabilities→
HCA Healthcare Stock
HCA Healthcare Equity→
HCA Healthcare Stock
HCA Healthcare AAQS→
HCA Healthcare Stock
HCA Healthcare Employees→
HCA Healthcare Stock
HCA Healthcare ROE→
HCA Healthcare Stock
HCA Healthcare ROA→
HCA Healthcare Stock
HCA Healthcare ROCE→
HCA Healthcare Stock
HCA Healthcare News→
HCA Healthcare Stock
HCA Healthcare Analyst Price Targets→

Health Stocks

Hcmed Innovations CoHC Surgical SpecialistsHCW BiologicsHBL Hadasit Bio HoldingsHealios KKHaw Par CorporationHealiusHassHealth CatalystHarvard BioscienceHealth DiscoveryHarvard Apparatus Regenerative TechnologyAll Stocks A–Z →